Early initiation of continuous renal replacement therapy improves clinical outcomes in patients with acute respiratory distress syndrome

American Journal of the Medical Sciences

Volumn 349, Issue 3, 2015, Pages 199-205

  Han, Fang ^a   Sun, Renhua ^a   Ni, Yin ^a   Hu, Xiuping ^a   Chen, Xv ^a   Jiang, Lingzhi ^a   Wu, Aiping ^a   Ma, Leilei ^a   Chen, Minhua ^a   Xv, Yunxiang ^a   Tu, Yuexing ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

ARDS; Critically ill; CRRT; Cytokines; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, HUMAN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CENTRAL VENOUS PRESSURE; CHINA; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUID BALANCE; FOLLOW UP; HEART INDEX; HEMODYNAMIC PARAMETERS; HUMAN; INTENSIVE CARE UNIT; LUNG COMPLIANCE; LUNG EXTRAVASCULAR FLUID; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; OXYGENATION; PILOT STUDY; POSITIVE END EXPIRATORY PRESSURE; SURVIVOR; BLOOD; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; EPIDEMIOLOGY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; RESPIRATORY DISTRESS SYNDROME, ADULT; TIME;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RENAL REPLACEMENT THERAPY; RESPIRATORY DISTRESS SYNDROME, ADULT; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84925685509     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0000000000000379     Document Type: Article

References (45)

1. Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-33
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-49
3. Bartram U, Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 2004;125:754-65
4. Hamacher J, Lucas R, Lijnen HR, et al. Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;166:651-6
5. Pittet JF, Griffiths MJ, Geiser T, et al. TGF-beta is a critical mediator of acute lung injury. J Clin Invest 2001;107:1537-44
6. Jenkins RG, Su X, Su G, et al. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 2006;116:1606-14
7. Budinger GR, Chandel NS, Donnelly HK, et al. Active transforming growth factor-beta1 activates the procollagen I promoter in patients with acute lung injury. Intensive Care Med 2005;31:121-8
8. Adams DH, Hathaway M, Shaw J, et al. Transforming growth factorbeta induces human T lymphocyte migration in vitro. J Immunol 1991; 147:609-12
9. Fahy RJ, Lichtenberger F, McKeegan CB, et al. The acute respiratory distress syndrome: a role for transforming growth factor-beta 1. Am J Respir Cell Mol Biol 2003;28:499-503
10. Beers MF, Solarin KO, Guttentag SH, et al. TGF-beta1 inhibits surfactant component expression and epithelial cell maturation in cultured human fetal lung. Am J Physiol 1998;275:L950-60
11. de Pablo R, Monserrat J, Reyes E, et al. Sepsis-induced acute respiratory distress syndrome with fatal outcome is associated to increased serum transforming growth factor beta-1 levels. Eur J Intern Med 2012; 23:358-62
12. Dhainaut JF, Charpentier J, Chiche JD. Transforming growth factorbeta: a mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med 2003;31(suppl 4):S258-64
13. Shenkar R, Coulson WF, Abraham E. Anti-transforming growth factor-beta monoclonal antibodies prevent lung injury in hemorrhaged mice. Am J Respir Cell Mol Biol 1994;11:351-7
14. Giri SN, Hyde DM, Hollinger MA. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 1993;48:959-66
15. Bellomo R, Honore PM, Matson J, et al. Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis. Int J Artif Organs 2005;28:450-8
16. Dirkes S, Hodge K. Continuous renal replacement therapy in the adult intensive care unit: history and current trends. Crit Care Nurse 2007;27: 61-6; 68-72, 74-80; quiz 81
17. Ronco C, Bonello M, Bordoni V, et al. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif 2004;22:164-74
18. Abdo AA, Castellanos R, Rocha M, et al. Continuous venovenous hemodiafiltration in patients with multiple organ dysfunction syndrome in an intensive care unit. MEDICC Rev 2012;14:26-30
19. Marenzi G, Lauri G, Grazi M, et al. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001;38:963-8
20. Sun Q, Liu ZH, Chen J, et al. An aggressive systematic strategy for acute respiratory distress syndrome caused by severe pneumonia after renal transplantation. Transpl Int 2006;19:110-16
21. DiCarlo JV, Alexander SR, Agarwal R, et al. Continuous venovenous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. J Pediatr Hematol Oncol 2003;25:801-5
22. Elbahlawan L, West NK, Avent Y, et al. Impact of continuous renal replacement therapy on oxygenation in children with acute lung injury after allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer 2010;55:540-5
23. Zhang JC, Chu YF, Zeng J, et al. Effect of continuous high-volume hemofiltration in patients with severe acute respiratory distress syndrome [in Chinese]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2013; 25:145-8
24. Garzia F, Todor R, Scalea T. Continuous arteriovenous hemofiltration countercurrent dialysis (CAVH-D) in acute respiratory failure (ARDS). J Trauma 1991;31:1277-84; discussion 1284-5
25. Liu CW, Zheng YK, Lu J, et al. Effect of high volume hemofiltration on respiration, hemodynamics and oxygen metabolism in sepsis with acute respiratory distress syndrome [in Chinese]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2006;18:657-60
26. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24
27. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-8
28. Kuzkov VV, Kirov MY, Sovershaev MA, et al. Extravascular lung water determined with single transpulmonary thermodilution correlates with the severity of sepsis-induced acute lung injury. Crit Care Med 2006;34:1647-53
29. Michard F. Bedside assessment of extravascular lung water by dilution methods: temptations and pitfalls. Crit Care Med 2007;35:1186-92
30. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012;122:2731-40
31. Sznajder JI. Alveolar edema must be cleared for the acute respiratory distress syndrome patient to survive. Am J Respir Crit Care Med 2001; 163:1293-4
32. Grasselli G, Foti G, Patroniti N, et al. A case of ARDS associated with influenza A-H1N1 infection treated with extracorporeal respiratory support. Minerva Anestesiol 2009;75:741-5
33. Schetz M. Non-renal indications for continuous renal replacement therapy. Kidney Int Suppl 1999;72:S88-94
34. Matsuda K, Moriguchi T, Oda S, et al. Efficacy of continuous hemodiafiltration with a cytokine-adsorbing hemofilter in the treatment of acute respiratory distress syndrome. Contrib Nephrol 2010; 166:83-92
35. Davenport A. Can modification of renal replacement therapy improve the outcome of patients with systemic inflammatory response syndrome?. Blood Purif 2006;24:317-18
36. Hoste EA, Vanholder RC, Lameire NH, et al. No early respiratory benefit with CVVHDF in patients with acute renal failure and acute lung injury. Nephrol Dial Transplant 2002;17:2153-8
37. Oh HJ, Shin DH, Lee MJ, et al. Early initiation of continuous renal replacement therapy improves patient survival in severe progressive septic acute kidney injury. J Crit Care 2012;27:e749-718
38. Bagshaw SM, Uchino S, Bellomo R, et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 2009;24:129-40
39. Seabra VF, Balk EM, Liangos O, et al. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis 2008;52:272-84
40. Karvellas CJ, Farhat MR, Sajjad I, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011;15:R72
41. Ronco C, Tetta C, Mariano F, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 2003;27:792-801
42. Meduri GU, Kohler G, Headley S, et al. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995;108:1303-14
43. Santana A, Saxena B, Noble NA, et al. Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycininduced pulmonary fibrosis. Am J Respir Cell Mol Biol 1995;13:34-44
44. Peters DM, Vadasz I, Wujak L, et al. TGF-beta directs trafficking of the epithelial sodium channel ENaC which has implications for ion and fluid transport in acute lung injury. Proc Natl Acad Sci U S A 2013;111: E374-83
45. Oda S, Sadahiro T, Hirayama Y, et al. Non-renal indications for continuous renal replacement therapy: current status in Japan. Contrib Nephrol 2010;166:47-53